Correlation of deviation from intended cisplatin (CDDP) dose intensity with outcome in patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) receiving concurrent chemoradiation (CRT)

被引：0
|
作者：
Liu, C. S.
Elser, C.
Huang, S.
Pond, G. R.
O'Sullivan, B.
Chen, E. X.
Waldron, J. N.
Goldstein, D.
Siu, L. L.
Kim, J.
机构：
[1] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada
[2] Everest Clin Res Serv, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.6052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6052
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Concurrent chemoradiation therapy for advanced head and neck squamous cell carcinoma (HNSCC) in a community hospital.
    Levine, MA
    Saunders, JR
    Zinreich, E
    Kunar, D
    Price, J
    Hirata, RM
    Williams, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 502S - 502S
  • [32] Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy (CCRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A randomized controlled multi-centered trial
    He, X.
    Yin, H.
    Guo, W.
    Sun, X.
    Hu, X.
    Yan, P.
    Li, F.
    Huang, S.
    Zhou, H.
    Zhang, F.
    Wang, B.
    Bian, X.
    Wei, Q.
    Wu, J.
    Wang, F.
    Song, D.
    Liu, J.
    Zhou, B.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Reporting of endpoints and tracking of failures in randomized trials of radiotherapy or concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer (LA-HNSCC)
    Le Tourneau, C.
    Michiels, S.
    Gan, H.
    Siu, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Results from a pilot study of nimotuzumab with concurrent chemoradiation in patients with locally advanced squamous cell carcinoma of head and neck
    Gupta, M.
    Madholia, V.
    Gupta, N.
    Bhowmik, K. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Pooled Analysis of Late Toxicity From 2 Randomized Phase 2 Trials of Induction Chemotherapy (IC) and Chemoradiation Therapy (CRT) for Locally Advanced Head and Neck Squamous Cell Cancer (LA-HNSCC)
    Melotek, J. M.
    Villaflor, V. M.
    Seiwert, T. Y.
    Kocherginsky, M.
    Karrison, T. G.
    Brisson, R. J.
    Blair, E. A.
    Stenson, K. M.
    Lingen, M.
    Cohen, E.
    Vokes, E. E.
    Haraf, D. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E351 - E352
  • [36] Multicenter phase II trial of nab-paclitaxel and cisplatin (AP) followed by chemoradiation therapy (CRT) for locally advanced head and neck squamous cell carcinoma (HNSCC)
    Adkins, D.
    Ley, J.
    Gay, H. A.
    Daly, M.
    Jackson, R.
    Rich, J.
    Pipkorn, P.
    Paniello, R. C.
    Trinkaus, K.
    Neupane, P.
    Zevallos, J.
    Thorstad, W.
    Oppelt, P.
    ANNALS OF ONCOLOGY, 2018, 29 : 381 - 381
  • [37] Impact of COVID19 pandemic on treatment outcome of locally-advanced head and neck squamous cell carcinoma (LA-HNSCC): IMPACCT study.
    Guillen Sentis, Pau
    Castillo Manzano, Carmen
    Quiros, Beatriz
    Morey Cortes, Francisca
    Tous, Sara
    Plana, Maria
    Brenes Castro, Jesus
    Lozano, Alicia
    Linares, Isabel
    Vilajosana Altamis, M. Esther
    Gomez Garcia, Victoria
    Labori Trias, Maria
    Goma, Montse
    Mari Roig, Antonio
    Bermejo, Oriol
    Tornero Salto, Jordi
    Taberna, Miren
    Alemany, Laia
    Mesia, Ricard
    Oliva Bernal, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] A randomized, multicenter, open phase II study of cetuximab with docetaxel, cisplatin as induction chemotherapy in unresectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
    Koh, Youngil
    Lee, Keun-Wook
    Kim, Sung-Bae
    Park, Kyong Hwa
    Shin, Sang Won
    Kang, Jin Hyoung
    Keam, Bhumsuk
    Lee, Se-Hoon
    Heo, Dae Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Efficacy and Safety of Aprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC): A Phase 2 Trial
    Zhang, Y.
    Yi, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S108 - S109
  • [40] Nimotuzumab in combination with intensity modulated radiotherapy improve survival in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A multicenterbased real-world study
    Yi, Junlin
    Lang, Jin Yi
    Zhang, Chenping
    Zhang, Xin-Xin
    Wu, Shao-xiong
    Sun, Yan
    Wang, Peiguo
    Qiu, Sufang
    Huang, Xiaodong
    Zhang, Peng
    Ren, Guoxin
    Liu, Kun
    Du, Xiao-Jing
    Xiao, Shaowen
    Wang, Zhong Qiu
    Weng, Youliang
    Zhang, Ye
    Zhou, Hang
    Tu, Wenyong
    Bai, Xianhong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345